Welcome to FANS Life Science Network meeting – The meeting will be held in English
Date: 19/6-2025
Time: 13.00 - 16.00 (followed by sandwich & networking)
Type: Hybrid (free to participate) Location: SAS Institute A/S, Havneholmen 8, 2450 København SV & Microsoft Teams.
Link to the Teams meeting will be sent with the confirmation mail after registration.
You will before the meeting be contacted to indicate if you participate physically or virtually.
Remember you get most out of the network meeting with physical participation!
Agenda
Welcome
By Anette Dalsgaard Jakobsen, Global Health and Life Sciences Practice, SAS & Frans Holm, SAS FANS
End2End automation in a pharma setup
By Vicky Poulsen, Standards Director, Novo Nordisk
AI Governance
Artificial Intelligence (AI) is revolutionizing drug development by accelerating target identification, clinical studies and ultimately getting drugs to patients faster.
As AI becomes integral to drug development, effective governance of the AI systems is critical for regulatory compliance, transparency, and trust.
This session will cover:
Introduction to AI Governance
How can SAS help with AI Governance?
AI Governance map : Assess where you are in your AI governance journey
By Anders Langgaard (Risk CXP SAS) & Anette Dalsgaard Jakobsen (Global Health and Life Sciences Practice).
Break
GIT integration in SAS products
Lars Arne will show how GIT is integrated in Enterprise Guide, Visual Studio Code and SAS Studio.
By Lars Arne Skår, SAS
Transforming Clinical Programming With SAS® Clinical Acceleration
In the rapidly evolving landscape of clinical research, managing vast amounts of data efficiently and securely is paramount.
SAS Clinical Acceleration offers a robust, cloud-native solution designed to streamline data management processes. This open repository enables researchers to store, access, and analyze clinical data with unprecedented ease and confidence. Leveraging advanced analytics and secure cloud infrastructure, SAS Clinical Acceleration ensures data integrity, compliance, and scalability.
By adopting this innovative platform, clinical researchers can focus on their core mission of advancing medical science, while benefiting from enhanced collaboration, reduced operational costs, and improved data-driven decision-making.
By Daniel Christen, Global Health and Life Sciences Customer Advisory, SAS
Closing
By Anette Dalsgaard Jakobsen, Global Health and Life Sciences Practice, SAS & Frans Holm, SAS FANS
After the network meeting there will be sandwiches and networking at Havneholmen.
You will, after the meeting, find the presentations from the meeting below.
... View more
